4//SEC Filing
Higgons John Duncan 4
Accession 0001640455-18-000084
CIK 0001640455other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:16 PM ET
Size
5.3 KB
Accession
0001640455-18-000084
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-19+13,550→ 13,550 totalExercise: $7.92Exp: 2028-06-19→ Common Stock (13,550 underlying)
Footnotes (1)
- [F1]The option will vest in equal quarterly installments during the four quarters following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001581954
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:16 PM ET
- Size
- 5.3 KB